Teva Hit With Securities Class Action Over CEO Resignation
Teva Pharmaceutical Industries Inc. was slapped with a putative class action in New York federal court on Wednesday when a shareholder alleged the company intentionally misled the media and investors about...To view the full article, register now.
Already a subscriber? Click here to view full article